These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23034205)

  • 1. Blood-brain barrier integrity in a zolpidem-responder patient.
    Nyakale NE; Clauss RP; Nel HW; Sathekge MM
    S Afr Med J; 2012 Jul; 102(10):790-1. PubMed ID: 23034205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and brain SPECT scan response to zolpidem in patients after brain damage.
    Nyakale NE; Clauss RP; Nel W; Sathekge M
    Arzneimittelforschung; 2010; 60(4):177-81. PubMed ID: 20486466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of zolpidem on brain injury and diaschisis as detected by 99mTc HMPAO brain SPECT in humans.
    Clauss RP; Nel WH
    Arzneimittelforschung; 2004; 54(10):641-6. PubMed ID: 15553102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zolpidem arouses patients in vegetative state after brain injury: quantitative evaluation and indications.
    Du B; Shan A; Zhang Y; Zhong X; Chen D; Cai K
    Am J Med Sci; 2014 Mar; 347(3):178-82. PubMed ID: 23462249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials.
    Sutton JA; Clauss RP
    Brain Inj; 2017; 31(8):1019-1027. PubMed ID: 28534652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraordinary arousal from semi-comatose state on zolpidem. A case report.
    Clauss RP; Güldenpfennig WM; Nel HW; Sathekge MM; Venkannagari RR
    S Afr Med J; 2000 Jan; 90(1):68-72. PubMed ID: 10721397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of 99mTc-DTPA SPECT of the blood-brain barrier with neurologic outcome after acute stroke.
    Lorberboym M; Lampl Y; Sadeh M
    J Nucl Med; 2003 Dec; 44(12):1898-904. PubMed ID: 14660714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral blood perfusion after treatment with zolpidem and flumazenil in the baboon.
    Clauss RP; Dormehl IC; Kilian E; Louw WK; Nel WH; Oliver DW
    Arzneimittelforschung; 2002; 52(10):740-4. PubMed ID: 12442636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Zolpidem for the Treatment of Disorders of Consciousness.
    Tucker C; Sandhu K
    Neurocrit Care; 2016 Jun; 24(3):488-93. PubMed ID: 26718349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of cerebral perfusion after zolpidem administration in the baboon model.
    Clauss RP; Dormehl IC; Oliver DW; Nel WH; Kilian E; Louw WK
    Arzneimittelforschung; 2001; 51(8):619-22. PubMed ID: 11556120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential benefits of zolpidem in disorders of consciousness.
    Noormandi A; Shahrokhi M; Khalili H
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):983-992. PubMed ID: 28649875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolpidem induces paradoxical metabolic and vascular changes in a patient with PVS.
    Rodriguez-Rojas R; Machado C; Alvarez L; Carballo M; Estevez M; Perez-Nellar J; Pavon N; Chinchilla M; Carrick FR; DeFina P
    Brain Inj; 2013; 27(11):1320-9. PubMed ID: 23924270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative Treatment of Intracranial Hypotension Venous Congestion-Associated Brain Injury With Zolpidem.
    Desmarais LM; Milleville KA; Wagner AK
    Am J Phys Med Rehabil; 2021 Jun; 100(6):e89-e92. PubMed ID: 32932357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common resting brain dynamics indicate a possible mechanism underlying zolpidem response in severe brain injury.
    Williams ST; Conte MM; Goldfine AM; Noirhomme Q; Gosseries O; Thonnard M; Beattie B; Hersh J; Katz DI; Victor JD; Laureys S; Schiff ND
    Elife; 2013 Nov; 2():e01157. PubMed ID: 24252875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zolpidem for the Treatment of Neurologic Disorders: A Systematic Review.
    Bomalaski MN; Claflin ES; Townsend W; Peterson MD
    JAMA Neurol; 2017 Sep; 74(9):1130-1139. PubMed ID: 28655027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA(A) alpha-1 subunit mediated desynchronization of elevated low frequency oscillations alleviates specific dysfunction in stroke--a case report.
    Hall SD; Yamawaki N; Fisher AE; Clauss RP; Woodhall GL; Stanford IM
    Clin Neurophysiol; 2010 Apr; 121(4):549-55. PubMed ID: 20097125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased arousal in a patient with anoxic brain injury after administration of zolpidem.
    Cohen SI; Duong TT
    Am J Phys Med Rehabil; 2008 Mar; 87(3):229-31. PubMed ID: 18174850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolpidem and restoration of consciousness--fact or fiction?
    Venter A
    S Afr Med J; 2015 Oct; 105(10):798. PubMed ID: 26636148
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient improvement of poststroke apathy with zolpidem: a single-case, placebo-controlled double-blind study.
    Autret K; Arnould A; Mathieu S; Azouvi P
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23396925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl pyruvate protects against blood-brain barrier damage and improves long-term neurological outcomes in a rat model of traumatic brain injury.
    Shi H; Wang HL; Pu HJ; Shi YJ; Zhang J; Zhang WT; Wang GH; Hu XM; Leak RK; Chen J; Gao YQ
    CNS Neurosci Ther; 2015 Apr; 21(4):374-84. PubMed ID: 25533312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.